VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > cha-ching

<< Previous

Bullboard Posts

Next >>

Comment by eyeNteeon Jan 26, 2021 5:41pm

212 Views

Post# 32391599

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:cha-ching

Simple.Adams has already given guidance that our market cap with our current approvals could easily be 100m..so still lots of upside..no need to hault trading or to comment..onwards and upwards..

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec